| Subject: | JC NPSG 3E - Evaluation of a Defined Anticoagulation Program |
| Category: | The Joint Commission (TJC)
|
| Published: | Fri, 21 Sep 2007 - 10:00 am |
| The Joint Commission's (JC) National Patient Safety Goal Requirement (NPSG) 3E requires organizations to reduce the likelihood of patient harm associated with the use of anticoagulation therapy. This notice reviews NPSG 3E Implementation Expectation 11, which requires organizations to evaluate their anticoagulation safety practices. NPSG 3E Expectation 11 also refers organizations to JC Standard MM.8.10, which requires that organizations evaluate their medication management... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
Related MCN Products:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards. |
|
